Aion Therapeutic Inc
CNSX:AION
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Aion Therapeutic Inc
CNSX:AION
|
CA |
|
Lotes Co Ltd
TWSE:3533
|
TW |
|
Nextracker Inc
NASDAQ:NXT
|
US |
|
Pretium Resources Inc
TSX:PVG
|
CA |
|
PIX Transmissions Ltd
NSE:PIXTRANS
|
IN |
|
Honeywell International Inc
NASDAQ:HON
|
US |
|
M&A Research Institute Holdings Inc
OTC:MAARF
|
JP |
|
Celltrion Inc
KRX:068270
|
KR |
Aion Therapeutic Inc
Aion Therapeutic, Inc. is an emerging international pharmaceutical company, which focuses on the healing powers of medical cannabis and medicinal mushroom compounds. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-02-21. The firm is focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis (cannabinoids), psychedelic mushrooms (psilocybin), fungi (edible mushroom), natural psychedelic formulations (Ayahuasca) and other medicinal plants for discovery.
Aion Therapeutic, Inc. is an emerging international pharmaceutical company, which focuses on the healing powers of medical cannabis and medicinal mushroom compounds. The company is headquartered in Toronto, Ontario. The company went IPO on 2019-02-21. The firm is focused on the development of combinatorial pharmaceuticals, nutraceuticals and cosmeceuticals utilizing compounds from cannabis (cannabinoids), psychedelic mushrooms (psilocybin), fungi (edible mushroom), natural psychedelic formulations (Ayahuasca) and other medicinal plants for discovery.
